Apollomics Inc.
Apollomics Inc is a Healthcare company operating in Biotechnology with a $50.1M market cap.
Behavioral analysis
Disclosures
Transcripts
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks APLM's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 50% positive reaction rate
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for APLM.
$ curl https://api.spokenalpha.com/v1/companies/APLMFAQ
Spoken Alpha indexes APLM's earnings call transcripts at https://spokenalpha.com/companies/APLM. Each call links to attributed speakers and parsed analyst Q&A.
Apollomics Inc. (APLM) operates in the Healthcare sector (Biotechnology industry).
Consistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.70 | $1.42 | +19.8% | -0.1% | -1.6% |
| Q4 FY2026 | $1.87 | $1.49 | +25.2% | +4.7% | +4.5% |
| Q3 FY2026 | $1.66 | $1.39 | +19.4% | -3.7% | -4.7% |
| Q2 FY2026 | $2.05 | $1.58 | +29.8% | +1.9% | +3.6% |
| Q1 FY2025 | $1.78 | $1.46 | +21.9% | +3.9% | +6.7% |
| Q4 FY2025 |
| $1.81 |
| $1.50 |
| +20.4% |
| -3.5% |
| -6.4% |
| Q3 FY2025 | $2.14 | $1.69 | +26.8% | -3.0% | -1.4% |
| Q2 FY2025 | $1.90 | $1.52 | +24.9% | +4.4% | +1.6% |
| Q1 FY2024 | $1.86 | $1.55 | +20.2% | -3.7% | -1.4% |
| Q4 FY2024 | $2.03 | $1.57 | +29.2% | +2.3% | +2.4% |